- SG$163.12m
- SG$929.53m
- CNY3.40bn
- 31
- 93
- 33
- 53
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,605 | 1,335 | 2,930 | 3,449 | 3,403 |
Cost of Revenue | |||||
Gross Profit | 882 | 386 | 328 | 513 | 832 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,053 | 991 | 1,738 | 3,135 | 2,786 |
Operating Profit | 551 | 345 | 1,191 | 313 | 617 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 240 | -201 | 1,041 | 233 | 344 |
Provision for Income Taxes | |||||
Net Income After Taxes | 149 | -276 | 799 | 187 | 268 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 138 | -55.6 | 816 | 139 | 176 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 138 | -55.6 | 421 | 137 | 176 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.179 | -0.385 | -0.345 | 0.089 | 0.224 |
Dividends per Share | |||||
Special Dividends per Share |